Virtual Reality Distraction for Anxiety Reduction During Trigger Points Procedures in Pain Medicine Clinic
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03334929|
Recruitment Status : Recruiting
First Posted : November 7, 2017
Last Update Posted : November 7, 2017
|Condition or disease||Intervention/treatment|
|Pain Management||Device: Virtual Reality headset|
trigger points can cause a wide range of pain symptoms; pain in the anterior shoulder and down the arm, headache pain, back pain, hip pain, knee pain, frozen shoulder pain, and other symptoms. Local anesthetic injections and lidocaine injections are common "wet" needling treatments for trigger points injections. The proposed mechanism by which trigger points injections alleviate pain is based on mechanical disruption of the taut bands of muscle with palpation based needling. During injections, patients may feel an intensified pain and a twitch response.
Distraction has been proved to be an effective tool in pain management, and it can also be used for a variety of medical procedures. By engaging in assigned tasks, pain and anxiety are assumed to be lessened throughout the procedure, while leaving patients less occupied by pain stimuli. . An immersive virtual environment may be preferable to medications such as sedatives, due to side effects and prolonged discharge from procedure suite. Occasionally, medications may not even be available in a busy interventional pain suite. At the UCD pain clinic, we do not offer sedating medications for bedside procedures like trigger point injections. By wearing VR headset, patients may feel less tense, anxious, and painful during trigger point injections.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Care Provider)|
|Official Title:||Virtual Reality Distraction for Anxiety Reduction During Trigger Points Procedures in Pain Medicine Clinic|
|Actual Study Start Date :||September 8, 2017|
|Estimated Primary Completion Date :||July 31, 2018|
|Estimated Study Completion Date :||August 31, 2018|
Experimental: Virtual Reality intervention
Participants will be wearing Virtual Reality headset called Oculus gear equipped with Samsung galaxy S7 during the trigger point injections. The VR app chosen is called Relax VR - Rest, Relaxation & Meditation, which will provide a calm beach scene with waves and soothing musics.
Device: Virtual Reality headset
The participants in this group would wear Virtual Reality headset called Oculus Gear VR during their trigger point injections.
No Intervention: control
Participants in this group will receive trigger point injections without any intervention. The trigger point injections will be performed in daily manner.
- anxiety level [ Time Frame: Approximately, it takes 30 minutes. It starts from answering the pre-procedural anxiety survey to finish answering the post-procedural anxiety survey. ]all patients will answer a survey named State-Trait Anxiety Inventory before their trigger points injections, and State Anxiety Inventory after their injections as well. Then we compare their change of anxiety scores, and seek if the change of scores is significantly differed among experimental group and control group.
- Pain score [ Time Frame: Approximately, it takes 30 minutes. ]before and after trigger point injections, patients will be asked to fill out their pain score in a scale of 0-10.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03334929
|Contact: Lingzhou Jiang, BSemail@example.com|
|United States, California|
|University of California, Davis||Recruiting|
|Sacramento, California, United States, 95817|
|Contact: Samir Sheth, MD 916-734-5042 firstname.lastname@example.org|
|Principal Investigator:||Naileshni Singh, MD||University of California, Davis|
|Principal Investigator:||Samir Sheth, MD||University of California, Davis|